Akili reports fourth quarter and full year 2023 financial results and provides business update

Boston--(business wire)--akili, inc. (nasdaq: akli), a leading digital medicine company, today reported its financial results for the quarter and full year ended december 31, 2023, and provided an update on business progress. “we continue to see clear demand for our innovative, digital therapeutics, particularly amidst the ongoing mental health crisis and increasing awareness of adult adhd prevalence,” said matt franklin, chief executive officer at akili. “our mid-year shift to a leaner, custom.
AKLI Ratings Summary
AKLI Quant Ranking